March 27, 2009 - SenoRx said this week that it has received the right to apply the CE Mark to its Contura MLB short-term breast radiation balloon catheter.

The multi-lumen radiation balloon delivers radiation to the tissue surrounding a lumpectomy cavity following surgery for breast cancer. The CE Mark applies to both the original size Contura MLB, which is designed for lumpectomy cavities of 4 to 5 centimeters in diameter, as well as the more recently cleared, larger-size Contura Shape Select MLB designed for cavities ranging from 4.5 to 6 cm.

"We believe having the ability to apply the CE Mark to Contura further strengthens our long-term international growth opportunities," said Lloyd Malchow, SenoRx president and CEO. "SenoRx is already marketing its EnCor Breast Biopsy system and GelMark line of tissue markers through local in-country distributors with breast imaging and/or radiology franchises in more than 30 select markets outside the United States. While Contura is currently only being sold in the U.S., we can now begin implementing commercialization plans for the product internationally. We expect to launch Contura in several countries outside the U.S. in 2009 and further expand internationally in a step-wise manner."

For more information: www.senorx.com


Additional Content

News | Radiology Business

April 10, 2026 — The radiation therapy team at The Ohio State University Wexner Medical Center, The James Cancer ...

Time April 10, 2026
arrow
News | Radiology Imaging

April 7, 2026 — Onvida Health and Siemens Healthineers have entered a 10-year Value Partnership¹ designed to bring the ...

Time April 09, 2026
arrow
News | FDA

March 20, 2026 — Siemens Healthineers recently announced its Varian TrueBeam radiotherapy systems, which include ...

Time March 24, 2026
arrow
News | Radiology Education

March 17, 2026 – The Center for Radiology Education (CRE) has announced a nationwide initiative to provide scholarships* ...

Time March 17, 2026
arrow
News | Radiopharmaceuticals and Tracers

Jan. 29, 2026 — The American Society for Radiation Oncology (ASTRO) has launched a national program creating Authorized ...

Time January 30, 2026
arrow
Subscribe Now